THOMAS INTERNATIONAL LIMITED
Company number 01568983 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B+
Explanation: The patient exhibits a strong and stable constitution, characterized by decades of operational longevity, excellent regulatory compliance, and a robust capital base. However, the lack of publicly visible detailed financial vitals (due to its "Small" company filing exemptions) and its total dependence on a parent organization prevent a perfect score. It is healthy, but its systemic health is inextricably linked to its parent company's wellbeing.
Key Vital Signs
1. Corporate Pulse (Compliance & Filing Status): Strong The company's regulatory heartbeat is steady and robust. Accounts and confirmation statements are up to date with no overdue filings. In medical terms, the patient is attending all its regular check-ups and showing no signs of administrative neglect, which is often a precursor to corporate failure.
2. Bone Density (Capital Foundation): Robust With a share capital of £440,002, the company possesses a solid skeletal structure. This is not a shell company operating on a shoestring; it has substantial equity invested into its framework, providing a healthy buffer against operational shocks.
3. Nervous System (Governance & Leadership): Stable with Minor Changes The board of directors features active, engaged leadership. There is a recent note of a director resignation (Adam Peter Carswell), which is akin to a minor shift in the nervous system. While not inherently a symptom of distress, leadership changes warrant monitoring to ensure no loss of operational memory or strategic focus.
4. Blood Work (Detailed Financial Metrics): Unavailable Because the company qualifies as "Small" under UK filing thresholds, it is exempt from publishing a detailed profit & loss account or full balance sheet breakdowns. Consequently, we cannot measure its cash flow circulation (liquidity) or its metabolic rate (profit margins). We can only assess its outward physical condition.
5. Genetic Lineage (Corporate Structure & History): Deep-Rooted Incorporated in 1981, this is a mature business that has survived multiple economic cycles. It operates under the umbrella of Thomas International Holdings Ltd, which owns more than 75% of its shares. The company acts as a vital organ within a larger corporate body.
Diagnosis
Condition: Stable, Subsidiary-Dependent Maintenance
The financial data reveals a business in good administrative health with no visible symptoms of distress. Having traded for over four decades—originally under the name Bertburn Limited and later Thomas International Management Systems Europe Limited—the entity has successfully evolved its focus toward HR tech and psychometric assessments (Management Consultancy).
However, because it is wholly subordinated to Thomas International Holdings Ltd (owning >75%), this entity does not operate as an independent organism. Its financial immune system is heavily subsidized by its parent. If the parent company experiences financial hypertension or distress, this subsidiary will inevitably suffer the systemic fallout. The recent director resignation suggests internal restructuring, which is common in subsidiary operations as parent companies optimize their group structures.
Recommendations
- Monitor the Parent's Vitals: Because the subsidiary's health is tied to the parent, stakeholders should routinely check the financial filings of Thomas International Holdings Ltd. A symptom of distress at the group level will quickly trickle down.
- Internal Circulation Check: While the company is legally exempt from filing detailed accounts, internal management must maintain strict cash flow monitoring. A healthy share capital is good, but cash flow is the oxygen that keeps the business breathing day-to-day.
- Director Transition Care: Ensure that the knowledge and responsibilities of the recently resigned director are smoothly transitioned to the remaining board members (McKeever and Blaydon) to prevent any temporary paralysis in decision-making.